July 19, 2026 a 09:31 am
Healthcare Stocks - Performance Analysis 📊
The healthcare sector has been a focal point for investors, characterized by diverse performances across its segments. Recent trends highlight the volatility within, with standout performers driving the market forward, while others lag behind. This analysis breaks down the top and underperformers over key periods, offering insight into potential investment strategies. The findings here could guide portfolio adjustments amid the sector's dynamic shifts.
Healthcare Stocks Performance One Week 📈
The one-week period exhibited a mixed performance among healthcare stocks, with ABT leading the pack with a notable positive return. Conversely, ISRG faced a significant drop, marking it as a key underperformer during this timespan.
| Stock | Performance (%) | Performance |
|---|---|---|
| ABT | 7.57 | |
| MRK | 3.27 | |
| ABBV | 2.65 | |
| AMGN | 0.89 | |
| TMO | 1.07 | |
| UNH | 0.37 | |
| LLY | -0.76 | |
| JNJ | -1.48 | |
| ISRG | -14.92 |
Healthcare Stocks Performance One Month 📈
Over the one-month period, ABBV showcased remarkable growth, emerging as the sector's top performer. Meanwhile, ISRG continued to underperform with a significant dip.
| Stock | Performance (%) | Performance |
|---|---|---|
| ABBV | 16.77 | |
| TMO | 13.96 | |
| ABT | 13.83 | |
| MRK | 11.76 | |
| JNJ | 10.63 | |
| AMGN | 8.39 | |
| LLY | 7.52 | |
| UNH | 6.31 | |
| ISRG | -14.65 |
Healthcare Stocks Performance Three Months 🟢
In the three-month analysis, UNH emerged as the standout, with substantial gains, whereas ISRG's continued decline was the largest among its peers. LLY and ABBV also demonstrated strong performances.
| Stock | Performance (%) | Performance |
|---|---|---|
| UNH | 28.53 | |
| LLY | 26.53 | |
| ABBV | 23.37 | |
| JNJ | 9.97 | |
| MRK | 9.66 | |
| ABT | 6.21 | |
| AMGN | 5.30 | |
| TMO | 2.78 | |
| ISRG | -27.00 |
Summary ✅
Across all examined periods, the healthcare sector displayed considerable variances in stock performance. UNH and ABBV were consistent leaders, suggesting strong growth potential for investors. ISRG's persistent decline raises caution regarding its investment viability. Active management and periodic review of healthcare portfolios are advised to navigate this sector's intricacies successfully.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years